$30.23
0.963.30%
Comments
Loading...
Number of Stock Holdings
59
Number of Bond Holdings
-
Total Holdings
59
Number of ETFs
-
Franklin Genomic Advancements ETF (BATS:HELX), Top Holdings
Franklin Genomic Advancements ETF (BATS: HELX)
| Ticker | Name | Share % | |
|---|---|---|---|
| MEDP | Medpace Holdings Inc | 6.31% | |
| VRTX | Nvaesrtex Pharmaceuticals Inc | 5.51% | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.18% | |
| DHR | Danaher Corp. | 5.14% | |
| TMO | Thermo Fisher Scientific Inc | 4.85% | |
| KRYS | Krystal Biotech Inc | 4.80% | |
| LLY | Eli Lilly & Co. | 4.17% | |
| KR | Samsung Biologics Co Ltd | 3.30% | |
| NTRA | Natera Inc | 3.04% | |
| LN | Astrazeneca Plc, ADR | 2.60% | |
FAQ
How has HELX ETF performed?
The HELX ETF is currently trading at $30.23, which represents a 3.30% change. Over the past 52 weeks, the ETF has traded as high as $33.98 and as low as $28.30.
What is the expense ratio for HELX?
The expense ratio of HELX is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.
What is the Assets Under Management (AUM) for HELX?
The total Assets Under Management (AUM) for HELX is 9.70M. This represents the total market value of the assets managed by the ETF.
What is the investment style for HELX?
HELX follows a Mid Cap Growth investment style.
What are the top holdings for HELX?
The top holdings of HELX include: MEDP (6.31%), VRTX (5.51%), REGN (5.18%), DHR (5.14%), TMO (4.85%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for HELX?
Average daily volume data for HELX is currently not available.